Qiagen INC:1110297 [17-038689]
Ended Awarded
- Contract number
- HHSN26100004
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,633
Award facts
- Contract value 100% obligated
- $24,632.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC received a Blanket Purchase Agreement (BPA) call contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health, valued at $24,632.58. The contract, awarded on July 6, 2017, with an ultimate completion date of July 3, 2018, was issued without set-aside designation, reflecting the contractor's ability to compete in the open federal marketplace. The award utilized fixed-price pricing with economic price adjustment terms and represents a call against Qiagen's existing BPA vehicle with the federal government.
Qiagen, LLC, a Maryland-based subsidiary of Netherlands-headquartered Qiagen N.V., is a leading provider of molecular diagnostics, scientific equipment, and bioinformatics solutions to federal agencies. The company specializes in DNA and RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, and precision medicine analysis tools. This NCI contract aligns with Qiagen's established role as a key supplier of specialized laboratory reagents and equipment to the research and healthcare arms of the federal government, supporting the Institute's cancer research and diagnostic initiatives.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to Qiagen, LLC by National Cancer Institute (National Institutes of Health) on July 6, 2017.
How much is contract HHSN26100004 worth?
The government has obligated $24,633 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award